Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Journal of Colloid and Interface Science|December 26, 2022
From Hofmeister to hydrotrope: Effect of anion hydrocarbon chain length on a polymer brushHayden Robertson, Joshua D Willott, Kasimir P Gregory, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Haematologica|September 25, 2025
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry studyEliza Chung, Luke Wang, Cameron Wellard, et al.
Blood Advances|January 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature reviewLuke Wang, Eliza Chung, Cameron Wellard, et al.
British Journal of Haematology|July 17, 2026
End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative studyChathuri Abeyakoon, Cameron Wellard, Vanessa Murad, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II TrialMatthew Matasar, Nancy L Bartlett, Mazyar Shadman, et al.
British Journal of Haematology|June 26, 2019
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma AllianceJoel C Wight, Mimi Yue, Colm Keane, et al.
Cancer Discovery|January 13, 2021
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid LeukemiaStefan Bjelosevic, Emily Gruber, Andrea Newbold, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Aryl sulfonamides as selective PDE4 inhibitorsJ G Montana, G M Buckley, N Cooper, et al.
British Journal of Haematology|March 14, 2024
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance studyKate Manos, Leonid Churilov, Andrew Grigg, et al.
Pageof 27